SynthesisJournal of clinical hypertension (Greenwich, Conn.)2023
Effectiveness of mHealth interventions for improving hypertension control in uncontrolled hypertensive patients: A meta-analysis of randomized controlled trials.
Synthesis in Journal of clinical hypertension (Greenwich, Conn.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.
- Behavior Change Techniques Used in Self-Management Interventions Based on mHealth Apps for Adults With Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.Journal of medical Internet research · 2024Pooled it
- Effectiveness of mHealth interventions for improving hypertension control in uncontrolled hypertensive patients: A meta-analysis of randomized controlled trials.Journal of clinical hypertension (Greenwich, Conn.) · 2023Pooled it
- Development of a Health Behavioral Digital Intervention for Patients With Hypertension Based on an Intelligent Health Promotion System and WeChat: Randomized Controlled Trial.JMIR mHealth and uHealth · 2024Trial
- WeChat in China's mobile health: a bibliometric analysis of trends, hotspots, and academic contributions.JAMIA open · 2026Review
- Heterogeneous associations of a mobile health-based disease management program on uncontrolled hypertension: A target trial emulation study.PLOS digital health · 2026Article
- Systematic review of the impact of digital health technologies on blood pressure control and treatment adherence in young and middle-aged hypertensive patients.Frontiers in cardiovascular medicine · 2026Review
- Stress, Anxiety, and Self-Efficacy in Hypertension: Evidence from a Romanian Case-Control Study.Diseases (Basel, Switzerland) · 2025Article
- Development and evaluation of an IoT-based hypertension surveillance system in community health settings: a mixed-methods quasi-experimental study protocol.BMC health services research · 2025Article
- Quantifying the association of Life's Crucial 9 with cardiovascular diseases among elderly hypertensive patients managed in primary care settings.Population health metrics · 2025Article
- Electronic health records-integrated mobile health interventions in primary care to improve hypertension management in Black/African American populations: a systematic review.Oxford open digital health · 2025Article
- Patterns of adherence to home blood pressure monitoring among men and women in the Electronic Framingham Heart Study.PloS one · 2025Article
- Revolutionizing Hypertension Management in Type 2 Diabetes: The Promise of Digital Twin Technology.JACC. Advances · 2024Article
- The effect of a self-management programme on blood pressure levels among people with hypertension: a randomised controlled trial.Journal of research in nursing : JRN · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The benefits of mHealth interventions in uncontrolled hypertension are unclear. To determine whether mHealth effectively improves the control rate of uncontrolled hypertension. PubMed, Web of Science, EMBASE, Scopus, and Cochrane Library were searched for randomized controlled trials (RCTs) from January 2007 to September 2022. The intervention group consisted of mHealth intervention, and the control group was usual care. Random-effects meta-analysis models were used to assess pooled mHealth intervention effects and CIs. The primary outcome was the blood pressure (BP) control rate of uncontrolled hypertension. The secondary outcome was the change of BP. Thirteen RCTs were included in this meta-analysis, of which eight reported the successful BP control rate, 13 reported the change of systolic blood pressure (SBP), and 11 reported the change in diastolic blood pressure (DBP). The mean age of trial participants ranged from 47.7 to 66.9 years old, with a female composition ratio of 40.0%-66.1%. The duration of follow-up ranged from 3 to 18 months. This study showed a more robust effect size for improving BP control rate by mHealth interventions than usual care (57.5% vs. 40.8% of successful control rate; odds ratio [OR], 2.19 [95% CI, 1.32-3.62]). Furthermore, mHealth significantly reduced SBP by 4.45 mm Hg and DBP by 2.47 mm Hg, and subgroup analysis did not observe the major source of heterogeneity. This meta-analysis found that mHealth could significantly improve the uncontrolled hypertension control rate and might be a feasible, acceptable, and effective tool for uncontrolled hypertension management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.